These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 411191)

  • 21. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Willebrand factor in von Willebrand disease.
    Maragall S; Castillo R; Ordinas A; Liendo F; Rodríguez M
    Thromb Res; 1979; 14(2-3):495-500. PubMed ID: 312541
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgA inhibitor to factor VIII/von Willebrand factor.
    Gralnick HR; Flaum MA; Kessler CM; Zimbler H; Coller BS
    Br J Haematol; 1985 Jan; 59(1):149-58. PubMed ID: 3918558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagen-induced platelet aggregation is enhanced by bovine von Willebrand factor.
    Baugh RF; Jacoby JC; Brown JE
    Thromb Res; 1979; 16(1-2):289-94. PubMed ID: 315627
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative study of platelet aggregation in various species.
    Calkins J; Lane KP; LoSasso B; Thurber LE
    J Med; 1974; 5(5):292-6. PubMed ID: 4213003
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor.
    Brinkhous KM; Read MS
    Blood; 1980 Mar; 55(3):517-20. PubMed ID: 6965594
    [No Abstract]   [Full Text] [Related]  

  • 28. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ristocetin-Willebrand factor activity in dog plasma.
    Johnstone IB; Lotz F
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1128-34. PubMed ID: 6970064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease.
    Castillo R; Maragall S; Rodés J; Clemente C; Profitós J; Ordinas A
    Thromb Res; 1977 Dec; 11(6):899-906. PubMed ID: 304612
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Purification of ristocetin Willebrand factor (RWF).
    Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
    [No Abstract]   [Full Text] [Related]  

  • 33. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varied immunological reactivity of factor VIII from animal plasmas.
    Coppola R; Lombardi R; Hawkey C; Ruggeri ZM; Mannucci PM
    Thromb Res; 1980 Feb 1-15; 17(3-4):473-80. PubMed ID: 6768162
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nature of von Willebrand factor: a new assay and a specific inhibitor.
    Sarji KE; Stratton RD; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 38. Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats.
    de Gaetano G; Donati MB; Reyers-Degli Innocenti I; Roncaglioni MC
    Experientia; 1975 Apr; 31(4):500-2. PubMed ID: 1120536
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological studies of bovine platelet aggregating factor (PAF).
    Santos F; Wagner RH
    Thromb Res; 1979; 16(3-4):485-96. PubMed ID: 117566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.